{"id":"W4386272424","doi":"10.1159/000532064","title":"An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid","year":2023,"lang":"en","type":"article","venue":"Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tofacitinib; Keloid; Medicine; Janus kinase inhibitor; Janus kinase; Dermatology; Pharmacology; Fibroblast; Internal medicine; Wound healing; Lesion; Surgery; Cytokine; Rheumatoid arthritis; In vitro; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000412927,0.0002437005,0.001154669,0.0003086158,0.00007830469,0.00004024387,0.0002407007,0.0002794586,0.00005147362],"category_scores_gemma":[0.0002946543,0.0001511523,0.00003853703,0.0004811961,0.0003906011,0.0002406391,0.0001839262,0.0003056074,0.00002041774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002596479,"about_ca_system_score_gemma":0.0001812204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001377663,"about_ca_topic_score_gemma":0.0002253095,"domain_scores_codex":[0.9973676,0.0005341787,0.0008005131,0.0005193028,0.0003029924,0.0004754761],"domain_scores_gemma":[0.9986269,0.0002678796,0.000168141,0.0004649275,0.0001515763,0.0003206093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05363536,0.01512901,0.9140363,0.0000691266,0.0001220241,0.001686696,0.0002045435,9.965153e-7,0.0001574083,0.0001021723,0.0004651774,0.0143912],"study_design_scores_gemma":[0.5360414,0.02278818,0.4367044,0.00008818474,0.00009442736,0.0003859231,0.000269731,0.0007198814,0.0001926985,0.0003205696,0.002083087,0.0003115156],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962133,0.00005103107,0.000003032973,0.001031478,0.0002492542,0.001688548,0.00005306365,0.00006059526,0.0006497374],"genre_scores_gemma":[0.9986628,0.00004515053,0.0003412315,0.0003288075,0.00004695123,0.00009090414,0.0003881044,0.00002924562,0.00006679675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4824061,"threshold_uncertainty_score":0.616381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0854167968144067,"score_gpt":0.4213424748726338,"score_spread":0.3359256780582272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}